China’s Push into A.I. Has Led to a Problem: Too Much Usage
By Gammatek ISPL, Industrial Systems & Compliance Analyst at Gammatek ISPL
Last updated: September 2026 | 14 min read
Author block: Gammatek ISPL tracks enterprise AI adoption trends and their implications for manufacturing and industrial compliance at Gammatek ISPL. This piece draws on publicly reported data from Chinese government sources, Bloomberg, and academic research — not speculation or AI-generated summarization of competitor coverage.
Why This Matters
If you run or advise a business thinking about adopting AI tools — whether that's a chatbot for customer service, enterprise AI software for internal operations, or AI-assisted monitoring on a factory floor — China's experience is the closest thing we have to a live experiment in what happens when a government actively pushes AI adoption at massive scale. The headline number looks like unambiguous success: hundreds of millions of new users in under a year. But recent data and commentary coming out of China itself — including warnings from a major Chinese tech CEO — suggest that raw usage numbers can mask a much harder problem: a lot of AI activity without a lot of AI value. If your organization is being pushed toward "adopt AI everywhere, fast," China's current moment is worth understanding before you repeat the same pattern.
The Numbers Behind the Headline
China's National Internet Network Information Center reported the country had roughly 515 million generative AI users as of June, an increase of 266 million since the previous December — a near-doubling of the user base in about six months (source: Xinhua, via Bloomberg Opinion, October 2025). On its face, this looks like the clearest possible validation of Beijing's "AI Plus" initiative, a national strategy explicitly designed to embed AI technology across manufacturing, services, and consumer life.
The ambition behind that strategy is genuinely large in scope. China's State Council has set formal targets for AI-powered device adoption across industries — over 70% by 2027, and over 90% by 2030 (source: South China Morning Post, reporting on NDRC statements). That's not a soft aspiration; it's a government-mandated adoption curve, backed by state investment in computing capacity and coordinated rollout across regions.
The Quiet Warning From Inside China's Own Tech Industry
Here's what the raw growth numbers don't capture, and what's genuinely original about this moment: some of the loudest skepticism about this AI surge isn't coming from Western critics — it's coming from inside China's own tech industry and research institutions.
Baidu's CEO has publicly warned about the sheer proliferation of AI models in China, cautioning that the market now has "too many" competing large language models chasing the same narrow set of applications, resulting in wasted computing resources and a shortage of genuinely differentiated, useful products (source: China Daily Reads / industry reporting, 2024-2025). The concern isn't that China lacks AI capability — it's that intense, state-encouraged competition has produced duplication rather than depth: dozens of similar chatbots competing for the same casual use cases (trip planning, food ordering, entertainment) while fewer resources go toward harder, more valuable enterprise and industrial applications.
China's own central economic planners appear to share a version of this concern. The National Development and Reform Commission has explicitly cautioned regions against "disorderly competition and blind expansion" in AI investment, urging a more tailored, locally-appropriate rollout instead of a nationwide rush (source: South China Morning Post, reporting on NDRC statements). When a government simultaneously pushes an aggressive adoption target and warns against blind over-investment, that tension is itself a signal worth paying attention to.
A More Specific Warning Sign: Healthcare
One of the more concrete illustrations of the "usage without enough scrutiny" problem comes from medicine, not casual chat apps. A group of medical researchers affiliated with Tsinghua University published findings in the medical journal JAMA raising concerns that healthcare institutions were adopting AI tools — specifically DeepSeek — faster than appropriate validation could keep pace, driven partly by social and institutional pressure not to appear "technologically backward" (source: JAMA, reported via independent China-focused analysis, 2025). The researchers noted a specific, concrete problem: patients increasingly arriving with AI-generated treatment recommendations and insisting doctors follow them, regardless of clinical judgment.
This example matters beyond healthcare because it's a clean illustration of a general pattern: when adoption is driven by social pressure and competitive anxiety rather than validated usefulness, usage volume grows faster than the quality controls needed to make that usage safe or productive.
Why This Pattern Isn't Unique to China
It would be easy to read this as a China-specific story, but the underlying dynamic — rapid AI adoption outpacing genuine integration and oversight — is a pattern any organization can fall into, including ones considering enterprise AI software adoption anywhere in the world. The specific failure mode China is surfacing at national scale (many users, overlapping tools, thin differentiation, uneven real-world value) is the same failure mode a single company risks at a much smaller scale when it rolls out AI tools across departments without a clear plan for what problem each tool is actually solving.
Adoption-Driven Rollout | Problem-Driven Rollout | |
Primary driver | Competitive/social pressure ("everyone else is using AI") | A specific, identified operational problem |
Tool selection | Whatever is trending or mandated | Matched to a defined use case |
Success metric | Number of users, volume of usage | Measurable outcome improvement (time saved, errors reduced, cost avoided) |
Oversight | Minimal, added after the fact if at all | Built in from the start — validation, audit trail, accountability |
Typical result | High usage numbers, unclear ROI | Lower usage numbers, but each use case defensible and measurable |
What This Means for Enterprise AI Adoption Decisions
For any organization — not just in China — evaluating enterprise AI software, this moment offers a genuinely useful cautionary framework rather than just an interesting data point:
1. Usage volume is a vanity metric unless tied to a specific outcome. A chatbot with millions of daily interactions that doesn't measurably reduce cost, time, or error rates isn't a success story — it's an expensive habit. The same logic applies whether you're evaluating a consumer AI assistant or enterprise AI software for internal operations: ask what specific problem it solves before asking how many people are using it.
2. Competitive anxiety is a bad reason to adopt AI tools. The Tsinghua researchers' finding — that hospitals adopted AI partly to avoid appearing "technologically backward" — is a warning any industry should take seriously. If the honest reason your organization is evaluating nvidia AI for enterprise deployment, a new enterprise AI software platform, or any AI tool is "our competitors are doing it," that's a weaker foundation than a clearly defined operational need.
3. Oversight needs to scale with usage, not follow it. China's own regulators flagging "disorderly" AI expansion after rapid growth already occurred is a pattern worth avoiding proactively: build validation, audit trails, and accountability into an AI rollout from the start, rather than retrofitting oversight once usage has already outpaced your ability to govern it.
4. More models or more tools isn't the same as more capability. Baidu's own CEO is warning about redundant, overlapping AI products competing for the same shallow use cases. The lesson for any company evaluating its own AI vendor landscape: consolidate around tools that solve genuinely different problems, rather than layering on more AI products that duplicate what you already have.
An Implementation Consideration for Manufacturing and Compliance Teams
This is directly relevant to industrial and manufacturing organizations specifically, where AI adoption is accelerating for predictive maintenance, compliance monitoring, and plant floor automation. The same discipline China's own planners are now calling for — tailored, validated rollout rather than blind expansion — applies directly to decisions like:
Whether a new AI-driven monitoring tool is solving an identified maintenance or safety problem, versus being adopted because "AI" is in the product description
Whether your organization can actually produce an audit trail showing how an AI-assisted compliance decision was reached, the way a regulator or auditor would require
Whether adding another enterprise AI software tool genuinely covers new ground, or duplicates a capability you already have under a different vendor
Plants that treat AI adoption as a problem-driven decision — not an adoption-driven one — are far less likely to end up in the position China's own tech leaders are now publicly warning about: enormous usage numbers, uncertain real value.
The Honest Takeaway
China's AI usage numbers are genuinely remarkable, and the country's industrial ambitions for AI are real, well-funded, and unlikely to slow down. But the clearest signal in this story isn't the 515 million user figure — it's that some of China's own most informed voices, from a major tech CEO to central economic planners to medical researchers, are independently converging on the same concern: scale without sufficient validation creates risk, not just progress. That's a lesson worth absorbing before replicating the growth-at-all-costs pattern anywhere else, including inside your own organization's AI rollout plans.
How Gammatek Approaches This Differently
Where China's experience shows the risk of adoption outpacing oversight, Gammatek's compliance and safety platform is built around the opposite principle: every AI-assisted monitoring or compliance feature we deploy for manufacturing and pharma clients comes with a built-in audit trail, so usage never outruns accountability. If your organization is evaluating AI tools for plant compliance or maintenance and wants a problem-driven rollout rather than an adoption-driven one, this is exactly the gap we help close.
See how Gammatek builds AI-assisted compliance monitoring with audit-ready oversight built in → https://www.gammateksolutions.com/post/it-s-all-fun-and-games-until-you-give-ai-your-credit-card https://www.gammateksolutions.com/post/top-mathematicians-are-outraged-by-openai-s-methods
Comments